Xvivo Perfusion AB (publ) (LON:0RKL)

Market Cap	459.15M
Revenue (ttm)	64.23M
Net Income (ttm)	2.36M
Shares Out	n/a
EPS (ttm)	0.07
PE Ratio	194.50
Forward PE	66.06
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,326
Average Volume	8,341
Open	176.40
Previous Close	174.51
Day's Range	175.68 - 181.10
52-Week Range	160.80 - 519.00
Beta	2.01
RSI	61.47
Earnings Date	Oct 23, 2025

About Xvivo Perfusion AB

Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates through Thoracic; Abdominal; Services; and other segments. The company offers Kidney Assist Transport, a portable device that allows hypothermic pulsatile perfusion of donor kidneys with oxygenated solution for up to 24 hours; Liver Assist that provides clinicians a choice of perfusion protocols whether hypothermic, normothermi...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1998
• Employees: 190
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RKL

Financial Performance

In 2024, Xvivo Perfusion AB's revenue was 822.42 million, an increase of 37.63% compared to the previous year's 597.54 million. Earnings were 172.18 million, an increase of 87.52%.

Financial numbers in SEK